Iceland· IS-EU/1/16/1097/001
Strimvelis
A other immunostimulants product containing autologous cd34+ enriched cell fraction that contains cd34+ cells transduced with retroviral vector that encodes for the human ada cdna sequence, registered in Iceland by Fondazione Telethon ETS. The same ATC class is registered in 8 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Autologous cd34+ enriched cell fraction that contains cd34+ cells transduced with retroviral vector that encodes for the human ada cdna sequence is registered in 8 of 19 countries.
Countries holding a registration under ATC L03AX (other immunostimulants), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 6 of them publish a price we can compare per daily dose
Autologous cd34+ enriched cell fraction that contains cd34+ cells transduced with retroviral vector that encodes for the human ada cdna sequence · ATC L03AX
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence
- Manufacturer
- Fondazione Telethon ETS
- Country
- Iceland (IS)
- ATC code
- L03AX
- ATC class
- Other immunostimulants
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Autologous cd34+ enriched cell fraction that contains cd34+ cells transduced with retroviral vector that encodes for the human ada cdna sequence in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumLibmeldy 2 10*6 cells/ml - 10 10*6 cells/mlOrchard Therapeutics (Netherlands)
- United StatesLENMELDYOrchard Therapeutics (Europe) Ltd
- SpainLIBMELDY 2-10 X 10^6 CELULAS/ML DISPERSION PARA PERFUSIONOrchard Therapeutics (Netherlands) B.V.
- FinlandLibmeldyOrchard Therapeutics (Netherlands) BV
- FranceLIBMELDY 2-10 x 1 000 000 cellules / ml, dispersion pour perfusionORCHARD THERAPEUTICS (NETHERLANDS) (PAYS-BAS)
- United KingdomLibmeldy 2million-10million cells/ml dispersion for infusion bagsOrchard Therapeutics (Europe) Ltd
- IrelandLibmeldy 2-10 x 106 cells/mL dispersion for infusionOrchard Therapeutics (Netherlands) B.V.
- NetherlandsLibmeldy 2-10 x 10^6 cellen/ml dispersie voor infusieOrchard Therapeutics (Netherlands) B.V.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Libmeldy, Strimvelis
- Norway · Libmeldy, Strimvelis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/832f84d9-1ac0-4701-9ed8-693c6ecd1568 GET /v1/drugs/832f84d9-1ac0-4701-9ed8-693c6ecd1568?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Innrennslislyf, ördreifa",
"source": "lyfjastofnun",
"atc_raw": "L03AX",
"marketed": false,
"strength": "1-10 milljón frumur/ml",
"ma_number": "EU/1/16/1097/001",
"substance": "Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence",
"other_info": "Markaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "42516"
}See everything about autologous cd34+ enriched cell fraction that contains cd34+ cells transduced with retroviral vector that encodes for the human ada cdna sequence.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.